REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Healthcare and pharma

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

1 2
Philippines Pharma and Healthcare Sector Report 2025-2026 - Page 1
Philippines Pharma and Healthcare Sector Report 2025-2026 EMIS Insights Industry Reports

The Philippines' healthcare system comprises both public and private components. Public healthcare is devolved to local government units, with the central government operating only a handful of tertiary care and specialist health facilities. ...

View more details
USD 995 Date: August 2025 Language: English
Format: PDF
Add to basket
ASEAN Pharma and Healthcare Sector Report 2025-2026 - Page 1
ASEAN Pharma and Healthcare Sector Report 2025-2026 EMIS Insights Industry Reports

Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...

View more details
USD 995 Date: June 2025 Language: English
Format: PDF
Add to basket
ASEAN Pharma and Healthcare Sector Report 2024-2025 - Page 1
ASEAN Pharma and Healthcare Sector Report 2024-2025 EMIS Insights Industry Reports

Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...

View more details
USD 995 Date: May 2024 Language: English
Format: PDF
Add to basket
Philippines Pharma and Healthcare Sector Report 2024-2025 - Page 1
Philippines Pharma and Healthcare Sector Report 2024-2025 EMIS Insights Industry Reports

The Philippines' healthcare system comprises both public and private components. In the Philippines, public healthcare is devolved to local government units, with the central government operating only a few tertiary care and specialist health ...

View more details
USD 995 Date: January 2024 Language: English
Format: PDF
Add to basket
Philippines Pharma and Healthcare Sector Report 2023-2024 - Page 1
Philippines Pharma and Healthcare Sector Report 2023-2024 EMIS Insights Industry Reports

The healthcare system in the Philippines comprises public and private components. Public healthcare in the Philippines is devolved to local government units, while the central government operates only a few tertiary care and specialist health ...

View more details
USD 995 Date: August 2023 Language: English
Format: PDF
Add to basket
USD 495 Date: January 2023 Language: English
Format: PDF
Add to basket
USD 495 Date: June 2022 Language: English
Format: PDF
Add to basket
Philippines Pharma and Healthcare Sector Report 2021-2022 - Page 1
Philippines Pharma and Healthcare Sector Report 2021-2022 EMIS Insights Industry Reports

The Philippines pharmaceuticals and healthcare sector is entering a phase of accelerated growth. The Philippines economy has grown considerably over the recent years, creating a growing middle-class population with the means to access ...

View more details
USD 495 Date: March 2021 Language: English
Format: PDF
Add to basket
Southeast Asia Pharma and Healthcare Sector Report 2021/2022 - Page 1
Southeast Asia Pharma and Healthcare Sector Report 2021/2022 EMIS Insights Industry Reports

The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...

View more details
USD 495 Date: March 2021 Language: English
Format: PDF
Add to basket
Southeast Asia Pharma and Healthcare Sector Report 2020/2024 - Page 1
Southeast Asia Pharma and Healthcare Sector Report 2020/2024 EMIS Insights Industry Reports

Healthcare remains in inadequate supply throughout most of the SEA region. The shortage is especially evident in healthcare human resources; for instance, apart from Malaysia and China, all the countries in the SEA region have fewer than 1 physician ...

View more details
USD 495 Date: August 2020 Language: English
Format: PDF
Add to basket
1 2